Decoding Treatment Resistant Depression

Get the latest information on treating patients with TRD from experts in the field!In March 2009, the FDA approved Symbyax (Lilly), a drug that combines Zyprexa and a long-acting form of Prozac, to treat patients with resistance to anti-depressants, a syndrome known as TRD. This ground-breaking drug could be the answer. Get the facts on this new drug and different strategies for TRD treatment and diagnosis from experts in the field. Written by thought leaders and researchers in clinical psychiatry, this handbook features up-to-date, cutting-edge information making it a must-have guide for every psychiatrist!